Skip to main content

Advertisement

Table 2 Summary of parasitological and clinical outcomes among patients treated with AS + SP after 28 days of follow-up

From: Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes

Classification Without PCR correction PCR-corrected
Number Proportion (95 % CI) Number Proportion (95 % CI)
ETF 0 0 (0) 0 0 (0)
LCF 5 5.8 (1.9, 13.0) 3 3.5 (0.7, 9.9)
LPF 0 0 (0) 0 0 (0)
ACPR 81 94.2 (87.0, 98.1) 83 96.5 (90.1, 99.3)
Total analysis 86    
WTH 1    
LFU 2 3.4   
Total 89    
  1. CI confidence interval, ACPR adequate clinical and parasitological response, ETF early treatment failure, LCF late clinical failure, LPF late parasitological failure, LFU loss to follow-up, WTH withdrawn